Peginterferon for chronic hepatitis B: Predicting success with on-treatment benchmarks

被引：7

作者：

Moucari, Rami ^{[1
,2
]}

机构：

[1] Hop Beaujon, Serv Hepatol, F-92110 Clichy, France

[2] Hop Beaujon, INSERM, U773, F-92110 Clichy, France

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2010年 / 25卷 / 09期

关键词：

SUSTAINED HBEAG; SERUM HBSAG; INTERFERON; SEROCONVERSION; SUPPRESSION; ALPHA-2A; THERAPY;

D O I：

10.1111/j.1440-1746.2010.06372.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1474 / 1475

页数：2

共 50 条

[1] Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline
Sonneveld, Milan J.
Rijckborst, Vincent
Boucher, Charles A. B.
Hansen, Bettina E.
Janssen, Harry L. A.
HEPATOLOGY, 2010, 52 (04) : 1251 - 1257
[2] On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients
Goulis, Ioannis
Karatapanis, Stylianos
Akriviadis, Evangelos
Deutsch, Melanie
Dalekos, George N.
Raptopoulou-Gigi, Maria
Mimidis, Konstantinos
Germanidis, George
Drakoulis, Christos
Triantos, Christos
Zintzaras, Elias
Bakalos, Georgios
Papatheodoridis, George
LIVER INTERNATIONAL, 2015, 35 (05) : 1540 - 1548
[3] Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels
Rijckborst, Vincent
Hansen, Bettina E.
Cakaloglu, Yilmaz
Ferenci, Peter
Tabak, Fehmi
Akdogan, Meral
Simon, Krzysztof
Akarca, Ulus S.
Flisiak, Robert
Verhey, Elke
Van Vuuren, Anneke J.
Boucher, Charles A. B.
ter Borg, Martijn J.
Janssen, Harry L. A.
HEPATOLOGY, 2010, 52 (02) : 454 - 461
[4] Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
Buster, Erik H. C. J.
Hansen, Bettina E.
Lau, George K. K.
Piratvisuth, Teerha
Zeuzem, Stefan
Steyerberg, Ewout W.
Janssen, Harry L. A.
GASTROENTEROLOGY, 2009, 137 (06) : 2002 - 2009
[5] On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients
Wong, Grace Lai-Hung
Wong, Vincent Wai-Sun
Choi, Paul Cheung-Lung
Chan, Anthony Wing-Hung
Chim, Angel Mei-Ling
Yiu, Karen Ka-Lam
Chu, Shirley Hoi-Ting
Chan, Francis Ka-Leung
Sung, Joseph Jao-Yao
Chan, Henry Lik-Yuen
ANTIVIRAL THERAPY, 2011, 16 (02) : 165 - 172
[6] Treatment with peginterferon versus interferon in Chinese patients with hepatitis B
Yu, Hai-bo
Liu, En-qi
Lu, She-min
Zhao, Si-hai
BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (08) : 559 - 564
[7] Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
Lok, Anna S.
Zoulim, Fabien
Dusheiko, Geoffrey
Chan, Henry L. Y.
Buti, Maria
Ghany, Marc G.
Gaggar, Anuj
Yang, Jenny C.
Wu, George
Flaherty, John F.
Subramanian, G. Mani
Locarnini, Stephen
Marcellin, Patrick
HEPATOLOGY COMMUNICATIONS, 2020, 4 (01) : 8 - 20
[8] On-treatment monitoring of chronic hepatitis B virus infection: An Asian-Pacific perspective
Chien, Rong-Nan
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (05) : 852 - 857
[9] Quantitative Hepatitis B Core Antibody Level Is a New Predictor for Treatment Response In HBeAg-positive Chronic Hepatitis B Patients Receiving Peginterferon
Hou, Feng-Qin
Song, Liu-Wei
Yuan, Quan
Fang, Lin-Lin
Ge, Sheng-Xiang
Zhang, Jun
Sheng, Ji-Fang
Xie, Dong-Ying
Shang, Jia
Wu, Shu-Huan
Sun, Yong-Tao
Wei, Shao-Feng
Wang, Mao-Rong
Wan, Mo-Bin
Jia, Ji-Dong
Luo, Guang-Han
Tang, Hong
Li, Shu-Chen
Niu, Jun-Qi
Zhou, Wei-dong
Sun, Li
Xia, Ning-Shao
Wang, Gui-Qiang
THERANOSTICS, 2015, 5 (03): : 218 - 226
[10] Models for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patients
Wang, Chang-Tai
Zhang, Ya-Fei
Sun, Bing-Hu
Dai, Yu
Zhu, Hui-Lan
Xu, Yuan-Hong
Lu, Meng-Ji
Yang, Dong-Liang
Li, Xu
Zhang, Zhen-Hua
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (18) : 5668 - 5676

← 1 2 3 4 5 →